Latest News

  • Alkermes Announces Clinical Collaboration With Fred Hutchinson Cancer Research Center for Novel Immuno-Oncology Drug Candidate ALKS 4230 Read More
  • Alkermes to Host Conference Call to Discuss Third Quarter 2019 Financial Results Read More
  • Alkermes Presents New Health Economics and Outcomes Research on Patients With Schizophrenia and Bipolar I Disorder at 2019 Psych Congress Read More

Investors

Working at Alkermes